ArticleAnalytical and bioanalytical chemistry2026
A self-powered biosensing platform utilizing gold-embedded hierarchical porous carbon and enzymatic signal amplification for aflatoxin B1 detection.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Current methods for detecting biotoxins are hindered by complex sample preparation and dependence on sophisticated instrumentation. Consequently, there is an urgent need for innovative solutions that facilitate efficient and portable detection capabilities. Herein, a self-powered biosensing platform based on enzyme-based biofuel cells (EBFCs) is reported for the first time for ultrasensitive detection of aflatoxin B1 (AFB1), utilizing gold-embedded hierarchical porous carbon (Au@HPC) and enzymatic signal amplification. Au@HPC was prepared to function as an electrode material of EBFCs for constructing superior EBFCs, representing a novel application of this composite in a self-powered sensing platform. An aptamer-based selective recognition strategy coupled with enzymatic signal amplification was further implemented to monitor the bioelectrocatalytic response toward AFB1. Synergy of enzymatic signal amplification and high-performance carrier material (Au@HPC) amplified electrical signals, markedly improving the sensitivity of the detection platform. As a result, AFB1 could be reliably identified over a wide concentration range of 0.01-10
Indexed as
Identifiers
41949607What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.